Descriptive Pilot Study of the Effects of a Standardized Neuromodulation Program on Cortical Brain Function in Chronic Low Back Pain Patients
NCT ID: NCT03929952
Last Updated: 2025-01-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2022-01-19
2024-10-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neurofeedback Treatment of Pain in Persons With Spinal Cord Injury (SCI)
NCT00947999
Brain Network fMRI Analysis in Proprioceptive Training for Chronic Low Back Pain
NCT07308249
Brain, Brainstem, and Spinal Cord fMRI
NCT02356315
Imaging Study of Chronic Low Back Pain in Patients Taking Pain Medication
NCT00388414
Increasing Sensori-Motor Rhythm Activity by EEG-Neurofeedback to Reduce the Impact of Pain on Daily Functioning
NCT06234917
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chronic low back pain
Neurofeedback treatment
20 sessions of neurofeedback of 5 minutes each consisting of :
* The patient is equipped with an electroencephalography headset. The feedback visual has the form of a candle flame and is modulated by alpha synchrony.
* The height of the flame is proportional to the intensity of the patient's pain. The patient has to concentrate on the height of this flame by thought to modulate it and, at the same time, to decrease the intensity of his own pain.
functional magnetic resonance imaging (fMRI) scans
The patient in alpha synchrony related state and in rating state will undergo an fMRI
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neurofeedback treatment
20 sessions of neurofeedback of 5 minutes each consisting of :
* The patient is equipped with an electroencephalography headset. The feedback visual has the form of a candle flame and is modulated by alpha synchrony.
* The height of the flame is proportional to the intensity of the patient's pain. The patient has to concentrate on the height of this flame by thought to modulate it and, at the same time, to decrease the intensity of his own pain.
functional magnetic resonance imaging (fMRI) scans
The patient in alpha synchrony related state and in rating state will undergo an fMRI
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with the ability to modulate the height of the candle by thinking in the alpha synchrony test.
* Patient with chronic low back pain for more than six months with a visual analogue pain scale greater than 5 impacting activities of daily living, hobbies and work
* Patient having given free and informed consent and signed consent.
* Affected patient or beneficiary of a health insurance plan.
* Patient who is at least 18 years old (≥) and younger than 75 years old (\<).
Exclusion Criteria
* Patient with a contraindication to performing a fMRI scan: ferromagnetic implant in the body, piercing, claustrophobia, unable to remain in the scanner stationary for 40 minutes
* Patient already included in another study
* Patient in a exclusion period determined by a previous study
* The subject is under the protection of justice, guardianship or curatorship.
* The subject refuses to sign the consent.
* It is not possible to give the subject informed information.
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nīmes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arnaud Dupeyron, MD
Role: PRINCIPAL_INVESTIGATOR
Nîmes University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nimes University Hospital
Nîmes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-A00437-34
Identifier Type: OTHER
Identifier Source: secondary_id
NIMAO/2018-01/AD-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.